Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
Regulation of CD45 Alternative Splicing by Heterogeneous Ribonucleoprotein, hnRNPLL
Shalini Oberdoerffer,1
Luis Ferreira Moita,2*
Daniel Neems,1
Rui P. Freitas,2*
Nir Hacohen,2,3
Anjana Rao1
Abstract:
The transition from naïve to activated T cells is markedby alternative splicing of pre-mRNA encoding the transmembranephosphatase CD45. Using a short hairpin RNA interference screen,we identified heterogeneous ribonucleoprotein L-like (hnRNPLL)as a critical inducible regulator of CD45 alternative splicing.HnRNPLL was up-regulated in stimulated T cells, bound CD45 transcripts,and was both necessary and sufficient for CD45 alternative splicing.Depletion or overexpression of hnRNPLL in B and T cell linesand primary T cells resulted in reciprocal alteration of CD45RAand RO expression. Exon array analysis suggested that hnRNPLLacts as a global regulator of alternative splicing in activatedT cells. Induction of hnRNPLL during hematopoietic cell activationand differentiation may allow cells to rapidly shift their transcriptomesto favor proliferation and inhibit cell death.
1 Department of Pathology, Immune Disease Institute, Harvard Medical School, Boston, MA 02115, USA. 2 Center for Immunology and Inflammatory Diseases, Division of Rheumatology, Allergy, and Immunology, Massachusetts General Hospital, Charlestown, MA 02129, USA. 3 Broad Institute of Harvard and Massachusetts Institute of Technology, Cambridge, MA 02142, USA.
* Present address: Instituto de Medicina Molecular, Faculdadede Medicina, Universidade de Lisboa, 1649-028 Lisboa, Portugal.
To whom correspondence should be addressed. E-mail: arao{at}idi.harvard.edu
The editors suggest the following Related Resources on Science sites:
In Science Magazine
PERSPECTIVES
Nick Holmes (1 August 2008) Science321 (5889), 646.
[DOI: 10.1126/science.1162294] |Summary »|Full Text »|PDF »
In Science Signaling
EDITORS' CHOICE
Katrina L. Kelner (5 August 2008) Sci. Signal.1 (31), ec283.
[DOI: 10.1126/scisignal.131ec283] |Abstract »
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Heterogeneous nuclear ribonucleoprotein L-like (hnRNPLL) and elongation factor, RNA polymerase II, 2 (ELL2) are regulators of mRNA processing in plasma cells.
M. J. Benson, T. Aijo, X. Chang, J. Gagnon, U. J. Pape, V. Anantharaman, L. Aravind, J.-P. Pursiheimo, S. Oberdoerffer, X. S. Liu, et al. (2012)
PNAS
109, 16252-16257
|Abstract »|Full Text »|PDF »
HnRNP L and L-like cooperate in multiple-exon regulation of CD45 alternative splicing.
M. Preussner, S. Schreiner, L.-H. Hung, M. Porstner, H.-M. Jack, V. Benes, G. Ratsch, and A. Bindereif (2012)
Nucleic Acids Res.
40, 5666-5678
|Abstract »|Full Text »|PDF »
A Conserved Serine of Heterogeneous Nuclear Ribonucleoprotein L (hnRNP L) Mediates Depolarization-regulated Alternative Splicing of Potassium Channels.
G. Liu, A. Razanau, Y. Hai, J. Yu, M. Sohail, V. G. Lobo, J. Chu, S. K. P. Kung, and J. Xie (2012)
J. Biol. Chem.
287, 22709-22716
|Abstract »|Full Text »|PDF »
Alternative Splicing Controlled by Heterogeneous Nuclear Ribonucleoprotein L Regulates Development, Proliferation, and Migration of Thymic Pre-T Cells.
M.-C. Gaudreau, F. Heyd, R. Bastien, B. Wilhelm, and T. Moroy (2012)
J. Immunol.
188, 5377-5388
|Abstract »|Full Text »|PDF »
Generation of CD19-chimeric antigen receptor modified CD8+ T cells derived from virus-specific central memory T cells.
S. Terakura, T. N. Yamamoto, R. A. Gardner, C. J. Turtle, M. C. Jensen, and S. R. Riddell (2012)
Blood
119, 72-82
|Abstract »|Full Text »|PDF »
Pivotal Advance: CD45RB glycosylation is specifically regulated during human peripheral B cell differentiation.
S. Koethe, L. Zander, S. Koster, A. Annan, A. Ebenfelt, J. Spencer, and M. Bemark (2011)
J. Leukoc. Biol.
90, 5-19
|Abstract »|Full Text »|PDF »
Identification of Tat-SF1 cellular targets by exon array analysis reveals dual roles in transcription and splicing.
H. B. Miller, T. J. Robinson, R. Gordan, A. J. Hartemink, and M. A. Garcia-Blanco (2011)
RNA
17, 665-674
|Abstract »|Full Text »|PDF »
Consequences of Increased CD45RA and RC Isoforms for TCR Signaling and Peripheral T Cell Deficiency Resulting from Heterogeneous Nuclear Ribonucleoprotein L-Like Mutation.
Z. Wu, A. L. Yates, G. F. Hoyne, and C. C. Goodnow (2010)
J. Immunol.
185, 231-238
|Abstract »|Full Text »|PDF »
RNA Interference Screen in Primary Human T Cells Reveals FLT3 as a Modulator of IL-10 Levels.
A. L. Astier, G. Beriou, T. M. Eisenhaure, S. M. Anderton, D. A. Hafler, and N. Hacohen (2010)
J. Immunol.
184, 685-693
|Abstract »|Full Text »|PDF »
Nucleosomes are well positioned in exons and carry characteristic histone modifications.
R. Andersson, S. Enroth, A. Rada-Iglesias, C. Wadelius, and J. Komorowski (2009)
Genome Res.
19, 1732-1741
|Abstract »|Full Text »|PDF »
Auto- and Cross-Regulation of the hnRNP L Proteins by Alternative Splicing.
O. Rossbach, L.-H. Hung, S. Schreiner, I. Grishina, M. Heiner, J. Hui, and A. Bindereif (2009)
Mol. Cell. Biol.
29, 1442-1451
|Abstract »|Full Text »|PDF »
The Heterogeneous Nuclear Ribonucleoprotein L Is an Essential Component in the Ca2+/Calmodulin-dependent Protein Kinase IV-regulated Alternative Splicing through Cytidine-Adenosine Repeats.
J. Yu, Y. Hai, G. Liu, T. Fang, S. K. P. Kung, and J. Xie (2009)
J. Biol. Chem.
284, 1505-1513
|Abstract »|Full Text »|PDF »
A cell-based screen for splicing regulators identifies hnRNP LL as a distinct signal-induced repressor of CD45 variable exon 4.
J. D. Topp, J. Jackson, A. A. Melton, and K. W. Lynch (2008)
RNA
14, 2038-2049
|Abstract »|Full Text »|PDF »